European agency prepares for new rules to improve drug safety

BMJ 2012; 344 doi: (Published 07 February 2012) Cite this as: BMJ 2012;344:e955
  1. Rory Watson
  1. 1Brussels

The London based European Medicines Agency is stepping up its preparations for new EU pharmacovigilance legislation that will come into force in July and will introduce the biggest change in the legal framework since the agency was established in 1995.

Among other changes, patients in Europe will for the first time be given the right to report suspected adverse reactions to national drug authorities, a right that already exists in the United Kingdom and some other European countries.

Adopted …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial